Fingerprint
Dive into the research topics of 'The Phase II/III transition toward the proof of efficacy in cancer clinical trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The Phase II/III transition toward the proof of efficacy in cancer clinical trials
Melissa Fazzari, Glenn Heller, Howard I. Scher
Research output: Contribution to journal › Article › peer-review
46
Scopus
citations